Safety of Ginger Use in Pregnancy:
Results From a Large Population-based
Cohort Study

FROM:   Eur J Clin Pharmacol. 2013 (Feb);   69 (2):   269–277

Kristine Heitmann , Hedvig Nordeng, Lone Holst

Department of Public Health and Primary Health Care
and Centre of Pharmacy,
University of Bergen,
P.O. Box 7804, 5020,
Bergen, Norway,
kristine.heitmann@isf.uib.no

---

PURPOSE:   The objective of the study was to examine the safety of ginger use during pregnancy on congenital malformations and selected pregnancy outcomes.

METHODS:   The Norwegian Mother and Child Cohort study, a large population-based cohort, provided the data used in this study. Our study population consisted of 68,522 women. Data on ginger use and socio-demographic factors were retrieved from three self-administered questionnaires completed by the women during weeks 17 and 30 of the pregnancy and when their child was 6 months old. Data on pregnancy outcomes were provided by the Medical Birth Registry of Norway.

RESULTS:   Among the 68,522 women in the study, 1,020 (1.5 %) women reported using ginger during pregnancy. The use of ginger during pregnancy was not associated with any increased risk of congenital malformations. No increased risk for stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score was detected for the women exposed to ginger during pregnancy compared to women who had not been exposed.

CONCLUSION:   Use of ginger during pregnancy does not seem to increase the risk of congenital malformations, stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score. This finding is clinically important for health care professionals giving advice to pregnant women with NPV.

Return to GINGER

Return to PREGNANCY AND CHIROPRACTIC

Since 6-15-2012